African Americans In Clinical Trials

African Americans in Clinical Trials

What should I know about clinical trials?

Many doctors think of clinical trials as another treatment option for multiple myeloma.

Clinical trials are necessary for new medicines to be approved by the US Food and Drug Administration (FDA). They have played a major role in advancing the treatment of multiple myeloma, and without these trials and the patients who voluntarily participated in them, we would not have the treatment options we have today.

When you participate in a clinical trial, you add to the knowledge about cancer and help improve cancer care. It is through clinical trials that researchers can determine whether new treatments are safe and effective and work better than current treatments.

Why does it matter who joins a clinical trial?

African Americans make up almost a quarter of people living with multiple myeloma today. Yet only 8% of patients in cancer clinical trials are African American. Therefore, it is important that they are represented in clinical trials to better understand and address the needs of African Americans.

Participation in US cancer clinical trials: 8% African American; 92% all other races.

What should I know about joining a clinical trial?

  • There are both benefits and risks to clinical trial participation. Talk to your doctor to learn more
  • People who participate in clinical trials for a cancer drug will typically receive a current standard treatment or the new drug being studied
  • You are free to quit the trial at any time if you experience unwanted side effects, if the treatment is not working for you, or for any reason at all
  • If early results show that one group being studied is seeing a clear, significant benefit over the other group, the researchers will stop the study so that all volunteers can receive the better treatment

To learn more about clinical trials and how they work, watch the Understanding Clinical Trials video presented by Dr. Craig Cole.

If you’re interested in learning more about clinical trials, check out these helpful links:

Multiple Myeloma Research Foundation Clinical Trials Finder >

TrialCheck® Clinical Trial Search Engine >

SparkCures Listing of Multiple Myeloma Clinical Trials >

Information about these independent organizations is provided as an additional resource for obtaining information related to multiple myeloma. It does not indicate endorsement by Bristol-Myers Squibb Company of an organization or its communications.

Your healthcare team is your best source of information.

Download the Standing in the Gaap brochure to learn more about multiple myeloma and how the disease could affect African Americans differently.
Download the Standing in the Gaap brochure